Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
BackgroundAcute heart failure (AHF) is a serious medical condition with considerable morbidity and mortality ranging from 20%–30% within the first month following hospital admission. We aimed to evaluate the efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors administered within...
Saved in:
| Main Authors: | Ali Ibrahim Rahil, Tirth Bhavsar, Romman Fatima, Aparajitha Rajkumar, Joy Kumar, Hanif Al Majidan, Namrata Gajjala, Wodwentzky Lefranc, Fnu Deeksha, Harshitha Lingegowda, Muhammad Ehsan, Wajeeh Ur Rehman, Hasan Ahmad, Raheel Ahmed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1543153/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence
by: Ruggero Mazzotta, et al.
Published: (2025-08-01) -
Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors
by: Filip Rolski, et al.
Published: (2025-02-01) -
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
by: Dana Darwish, et al.
Published: (2025-06-01) -
Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
by: Linda Piras, et al.
Published: (2024-11-01) -
Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta‐analysis
by: Patrick Savage, et al.
Published: (2024-12-01)